How much funding has Synthis Therapeutics, Inc. raised?

Synthis Therapeutics, Inc. has raised $579K in total funding, most recently a Grant round.

Who are Synthis Therapeutics, Inc.'s investors?

Synthis Therapeutics, Inc.'s investors include National Institutes of Health.

When was Synthis Therapeutics, Inc. founded?

Synthis Therapeutics, Inc. was founded in 2018.

Where is Synthis Therapeutics, Inc. headquartered?

Synthis Therapeutics, Inc. is headquartered in NEW YORK, New York, United States.

What industry is Synthis Therapeutics, Inc. in?

Synthis Therapeutics, Inc. operates in Biotech, Healthcare.

How many employees does Synthis Therapeutics, Inc. have?

Synthis Therapeutics, Inc. has 1-10 employees.

Synthis Therapeutics, Inc.

Home | Synthistx

NEW YORK, United States · Founded 2018 · $579K raised

Biotech

Healthcare

Headquarters: NEW YORK, New York
Employees: 1–10
Founded: 2018
Business Model: B2B

Website: synthistx.com
Total Funding: $579K
Last Round: $579K GrantJan 2024
Rounds: 2

About

Synthis Therapeutics is a New York-based immuno-oncology biotech developing first-in-class anti-fibrotic antibody drug conjugates (ADCs) that selectively inhibit TGF-β in disease-driving cells. Its lead candidates SYN101 and SYN303 target cancer, IPF, myelofibrosis, and fibrotic diseases. The company has received SBIR awards from NHLBI and NCI and has been granted NYC lab space multiple times.

Summary

Synthis Therapeutics, Inc. is a Biotech company based in NEW YORK, United States, founded in 2018. It has raised $579K in total across 2 rounds, most recently a $579K Grant round in Jan 2024. Investors include National Institutes of Health.